Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alkermes Plc
(NQ:
ALKS
)
24.61
+0.01 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alkermes Plc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
Why Alkermes Stock Is Sinking Today
October 25, 2023
The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.
Via
The Motley Fool
Why NASDAQ:ALKS Is a Promising High-Growth Stock in the Midst of Consolidation.
October 23, 2023
ALKERMES PLC (NASDAQ:ALKS), a strong growth stock, setting up for a breakout.
Via
Chartmill
Alkermes Honors Women's Equality Day
August 28, 2023
Via
ACCESSWIRE
Earnings Preview: Alkermes
July 25, 2023
Via
Benzinga
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
October 25, 2023
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Alkermes Plummets In Huge Volume. Why One Analyst Says The Reaction Is Overdone.
October 23, 2023
Analysts say Alkermes' drug is clearly active. But investors have concerns.
Via
Investor's Business Daily
Where Alkermes Stands With Analysts
June 07, 2023
Via
Benzinga
Alkermes Earnings Perspective: Return On Capital Employed
April 27, 2023
Via
Benzinga
Analyst Expectations for Alkermes's Future
April 27, 2023
Via
Benzinga
The Latest Analyst Ratings for Alkermes
April 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
Via
Benzinga
A Preview Of Alkermes's Earnings
April 25, 2023
Via
Benzinga
While growth is established for NASDAQ:ALKS, the stock's valuation remains reasonable.
October 17, 2023
Looking for growth without the hefty price tag? Consider ALKERMES PLC (NASDAQ:ALKS).
Via
Chartmill
NASDAQ:ALKS is showing good growth, while it is not too expensive.
September 26, 2023
Despite its growth, ALKERMES PLC (NASDAQ:ALKS) remains within the realm of affordability.
Via
Chartmill
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
August 30, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
August 17, 2023
Via
Benzinga
3 Top Biotech Stocks Defying the Bear Market
August 10, 2023
Biotech is still booming, if you pick the right biotech stocks.
Via
The Motley Fool
Alkermes Clocks Over 100% Jump In Q2 Sales and Profits On Reinstated Product Royalty From Long-Acting Invega
July 26, 2023
Alkermes plc (NASDAQ: ALKS) reported Q2 adjusted EPS of $0.55 compared to $0.06 a year ago, missing the consensus of $0.56
Via
Benzinga
Sarissa Capital Urges Alkermes Shareholders to Vote “FOR” Sarah Schlesinger and “WITHHOLD” Incumbent Director Richard Gaynor
June 28, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Issues Presentation Highlighting Sarissa Nominees Are Qualified to Create Value for Alkermes Shareholders
June 26, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Independent Proxy Advisory Firm ISS Agrees With Sarissa Capital That Shareholders’ Interests Would Be Best Served With Direct Shareholder Representation on the Alkermes Board
June 22, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Independent Proxy Advisory Firm ISS Concludes That Sarissa Capital Has Made a Compelling Case for Change to the Alkermes Board
June 20, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Issues Presentation Highlighting the Need for Shareholder Representation on the Alkermes Board
June 15, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Urges Shareholders to Vote for Sarissa Nominees to Provide Much Needed Oversight and Accountability to Alkermes
June 13, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Sarissa Capital Highlights Misleading Claims Made by Alkermes in Its Attempt to Thwart Shareholder Representation on the Board
June 09, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Alkermes Raises FY23 Outlook Following Arbitration Award from Janssen Agreements
June 06, 2023
Via
Benzinga
Sarissa Urges Alkermes Shareholders to Vote the Universal Blue Card to Upgrade Alkermes for the Benefit of Shareholders
June 05, 2023
From
Sarissa Capital Management LP
Via
Business Wire
Alkermes Stock Sees Rising Relative Strength Rating
March 28, 2023
The Relative Strength (RS) Rating for Alkermes stock climbed into a new percentile Tuesday, as it got a lift from 69 to 77.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.